Aller au contenu
Trouver un autre spécialiste

Michaël Marchand-Gareau

Professeur, Faculté de médecine et des sciences de la santé
FMSS Département de chirurgie

Présentation

Sujet de recherche

Maladies de l'oeil et du système visuel

Disciplines de recherche

Ophtalmologie

Mots-clés

Ophtalmologie, Glaucome, Chirurgie de glaucome, Intelligence artificielle

Intérêts de recherche

Glaucome, Glaucome normotensif, Chirurgie de glaucome, Chirurgie de glaucome minimalement invasive (MIGS), Facteurs de risque de progression du glaucome, Intelligence artificielle en ophtalmologie

Centre de recherche

Centre de recherche du CHUS

Recherche clinique

Oui

Langues parlées et écrites

Anglais, Français

Diplômes

(2021). (Postdoctorat, Diplôme de fellowship - Glaucome chirurgical). University of California, Davis.

(2020). (Postdoctorat, Diplôme d'études spécialisées - Ophtalmologie). Université de Montréal.

(2015). (Doctorat, Médecine). Université de Montréal.

Titres de compétence

Fellow (FRCSC). Collège Royal des Médecins et Chirurgiens du Canada.

Médecin spécialiste en ophtalmologie. Collège des médecins du Québec.

Expérience académique

Ophtalmologiste (surspécialité en glaucome chirurgical). (2021-).

Professeur adjoint en ophtalmologie, Faculté de médecine et des sciences de la santé, Université de Sherbrooke. (2021-). Université de Sherbrooke. Canada.

Prix et distinctions

  • Médaille académique du Gouverneur général (niveau collégial). Gouverneur général du Canada. (Distinction).
  • Médaille académique du Gouverneur général (niveau secondaire). Gouverneur général du Canada. (Distinction).
  • Premier prix en recherche fondamentale de la Société des sciences vasculaires du Québec (SSVQ). Société des sciences vasculaires du Québec (SSVQ). (Prix).
  • Prix Roch Gagnon. Université de Montréal. (Prix).
  • Prix académique de la Légion Royale canadienne. Légion Royale canadienne. (Prix).

Financement

  • Subvention. (Obtenu). Chercheur principal. Bourse de recherche du Fonds de démarrage pour les professeurs de l'Université de Sherbrooke. (2023)

Publications

Articles de revue

  • Wu KY , Mina M , Carbonneau M , Marchand M , Tran SD. (2023). Advancements in Wearable and Implantable Intraocular Pressure Biosensors for Ophthalmology: A Comprehensive Review. Micromachines 14 (10), (Article publié).
  • Wu KY , Ashkar S , Jain S , Marchand M , Tran SD. (2023). Breaking Barriers in Eye Treatment: Polymeric Nano-Based Drug-Delivery System for Anterior Segment Diseases and Glaucoma. Polymers 15 (6), (Article publié).
  • Geoffrion D , Hassanaly SI , Marchand M , Daoud R , Agoumi Y , Harissi-Dagher M. (2022). Assessment of the Role and Timing of Glaucoma Surgery in Boston Keratoprosthesis Type 1 Patients. American journal of ophthalmology 235 249-257. (Article publié).
  • Marchand M , El-Khoury J , Harissi-Dagher M , Robert MC. (2022). Outcomes of first cases of DMEK at a Canadian university hospital centre. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 57 (3), 214-215. (Article publié).
  • El-Khazen Dupuis J , Marchand M , Javidi S , Nguyen TQT. (2021). Enophthalmos as the Initial Systemic Finding of Undiagnosed Metastatic Breast Carcinoma. International medical case reports journal 14 25-31. (Article publié).
  • Marchand M , Singh H , Agoumi Y. (2021). Micropulse trans-scleral laser therapy outcomes for uncontrolled glaucoma: a prospective 18-month study. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 56 (6), 371-378. (Article publié).
  • El-Khoury J , Marchand M , Allaire G , Robert MC. (2020). Conjunctival stromal tumour: case report and review of the literature. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 55 (5), e174-e175. (Article publié).
  • Marchand M , Harissi-Dagher M. (2020). Recurrent preseptal cellulitis in Boston keratoprosthesis type II implantation for ocular Stevens-Johnson syndrome. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 55 (2), e59-e61. (Article publié).
  • Marchand M , Harissi-Dagher M , Germain M , Thompson P , Robert MC. (2018). Serum drops for ocular surface disease: national survey of Canadian cornea specialists. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 53 (3), 266-271. (Article publié).

Autres contributions

Cours enseignés

  • Situations fréquentes neurosensorielles. MSP123. Université de Sherbrooke. Canada.

Gestion d'évènements

  • Organisateur. Journée annuelle de la recherche en ophtalmologie de l'Université de Sherbrooke. (Conférence).

Présentations

  • (2024). Comparative Study on Kahook Dual Blade Goniotomy Versus Istent Inject in Conjunction with Cataract Surgery: Retrospective Analysis Phase 2. ASCRS-ASOA Annual Meeting. Boston, États-Unis d'Amérique
  • (2024). Efficacy and Safety of Kahook Dual Blade Goniotomy and Trabecular Micro-Bypass Stent (iStent Inject) in Combination with Cataract Extraction: A Retrospective Study. 34th American Glaucoma Society (AGS) Annual Meeting. Huntington Beach, États-Unis d'Amérique
  • (2024). Evaluating ChatGPT’s Ophthalmology Performance: BCSC Clinical Images & Text with Pretraining. ASCRS-ASOA Annual Meeting. Boston, États-Unis d'Amérique
  • (2023). Efficacy and Safety of Kahook Dual Blade Goniotomy and Trabecular Micro- Bypass Stent (iStent Inject) in Combination with Cataract Extraction: A Retrospective Study. 26th Annual Meeting of the Vision Health Research Network (VHRN). Montreal, Canada
  • (2023). Kahook Dual Blade Goniotomy versus Trabecular Micro-Bypass Stent (iStent inject): Surgical Outcomes in Combination with Phacoemulsification. ASCRS-ASOA Annual Meeting. San Diego, États-Unis d'Amérique
  • (2023). Kahook Dual Blade Goniotomy versus Trabecular Micro-Bypass Stent (iStent inject): Surgical Outcomes in Combination with Phacoemulsification. University of Sherbrooke Annual Research Day of the Departments of Surgery and Anesthesiology. Sherbrooke, Canada
  • (2023). Kahook Dual Blade Goniotomy versus Trabecular Micro-Bypass Stent (iStent inject): Surgical Outcomes in Combination with Phacoemulsification. ARVO Annual Meeting. New Orleans, États-Unis d'Amérique
  • (2023). Le traitement minimalement invasif du glaucome au CHUS. Journée Scientifique Conjointe des Départements de Chirurgie et d’Anesthésiologie, Université de Sherbrooke. Sherbrooke, Canada
  • (2023). MIGS : nouvelles options dans le traitement minimalement invasif du glaucome. Innovations 2023, Centre de perfectionnement et de référence en optométrie (CPRO). Montreal, Canada
  • (2022). Assessment of the Role and Timing of Glaucoma Surgery in Boston Keratoprosthesis Type 1 Patients. 34th University of Montreal Annual Ophthalmology Research Day. Montreal, Canada
  • (2022). Kahook Dual Blade Goniotomy versus Trabecular Micro-Bypass Stent (iStent inject): Surgical Outcomes in the Minimally Invasive Treatment of Glaucoma in Combination with Phacoemulsification. University of Sherbrooke Annual Research Day of the Departments of Surgery and Anesthesiology. Sherbrooke, Canada
  • (2022). Role and Timing of Glaucoma Surgery in Boston Keratoprosthesis Type 1 Patients. Asia-Pacific Association of Cataract and Refractive Surgeons (APACRS) Annual Meeting. Seoul, Corée du Sud
  • (2021). Assessment of the Role and Timing of Glaucoma Surgery in Boston Keratoprosthesis Type 1 Patients. 9th World Glaucoma E-Congress (Virtual).
  • (2021). Assessment of the Role and Timing of Glaucoma Surgery in Boston Keratoprosthesis Type 1 Patients. American Academy of Ophthalmology (AAO) Annual Meeting. New Orleans, États-Unis d'Amérique
  • (2021). High-Frequency Ultrasound Biomicroscopy (UBM) Imaging of the Ciliary Body in Patients with Intraocular Inflammation. UC Davis Eye Center Annual Resident & Alumni Research Symposium. Sacramento, États-Unis d'Amérique
  • (2021). High-Frequency Ultrasound Biomicroscopy Imaging of the Ciliary Body in Patients with Intraocular Inflammation. Association for Research in Vision and Ophthalmology (ARVO) 2021 Annual Meeting. San Francisco, États-Unis d'Amérique
  • (2021). Prospective 18-month Evaluation of Micropulse Trans-scleral Cyclophotocoagulation Treatment Outcomes in Uncontrolled Glaucoma at a University Hospital Center. Annual Meeting and Exhibition of the Canadian Ophthalmological Society (Virtual).
  • (2021). Role and Timing of Glaucoma Surgery in Boston Keratoprosthesis Type 1 Patients. Canadian Ophthalmological Society (COS) Annual Meeting (Virtual).
  • (2021). Role and Timing of Glaucoma Surgery in Boston Keratoprosthesis Type 1 Patients. American Society of Cataract & Refractive Surgery (ASCRS) Annual Meeting (Virtual).
  • (2021). Role and Timing of Glaucoma Surgery in Boston Keratoprosthesis Type 1 Patients. European Society of Cataract & Refractive Surgeons (ESCRS) Meeting (Virtual).
  • (2019). Outcomes of Descemet Membrane Endothelial Keratoplasty (DMEK) at a Canadian University Hospital Center. 31st University of Montreal Annual Ophthalmology Research Day. Montreal, Canada
  • (2019). Outcomes of Descemet Membrane Endothelial Keratoplasty (DMEK) at a Canadian University Hospital Center. Annual Meeting and Exhibition of the Canadian Ophthalmological Society (COS). Québec, Canada
  • (2019). Treatment Outcomes of MicroPulse Trans-scleral Cyclophotocoagulation (mTSCPC) in Uncontrolled Glaucoma at the University of Montreal Hospital Center (CHUM). 31st University of Montreal Annual Ophthalmology Research Day. Montreal, Canada
  • (2018). Recurrent Preseptal Cellulitis in Boston Keratoprosthesis Type II Implantation for Ocular Stevens-Johnson Syndrome. Annual Meeting and Exhibition of the Canadian Ophthalmological Society (COS). Toronto, Canada
  • (2018). Recurrent Preseptal Cellulitis in Boston Keratoprosthesis Type II Implantation for Ocular Stevens-Johnson Syndrome. 30th University of Montreal Annual Ophthalmology Research Day. Montreal, Canada
  • (2018). Recurrent Preseptal Cellulitis in PMMA Keratoprosthesis Type II Implantation for Ocular Stevens-Johnson Syndrome. Annual Meeting of the American Academy of Ophthalmology (AAO). Chicago, États-Unis d'Amérique
  • (2018). Recurrent Preseptal Cellulitis in PMMA Keratoprosthesis Type II Implantation for Ocular Stevens-Johnson Syndrome. ASCRS-ASOA Annual Meeting. Washington, États-Unis d'Amérique
  • (2018). Treatment Outcomes of MicroPulse Trans-scleral Cyclophotocoagulation (mTSCPC) in Uncontrolled Glaucoma at the University of Montreal Hospital Center (CHUM). 30th University of Montreal Annual Ophthalmology Research Day. Montreal, Canada
  • (2017). The Use of Serum Drops for the Treatment of Ocular Surface Disease in Canada - a National Survey of Cornea Specialists. 29th University of Montreal Annual Ophthalmology Research Day. Montreal, Canada
  • (2017). The Use of Serum Drops for the Treatment of Ocular Surface Disease in Canada - a National Survey of Cornea Specialists. Annual Meeting and Exhibition of the Canadian Ophthalmological Society (COS). Montreal, Canada
  • (2017). The Use of Serum Drops for the Treatment of Ocular Surface Disease in Canada - a National Survey of Cornea Specialists. ASCRS-ASOA Annual Meeting. Los Angeles, États-Unis d'Amérique
  • (2015). Glaucoma Surgery in Boston Type 1 Keratoprosthesis Patients at the University of Montreal Hospital Center. ASCRS- ASOA Annual Meeting. San Diego, États-Unis d'Amérique
  • (2015). Glaucoma Surgery in Boston Type 1 Keratoprosthesis Patients at the University of Montreal Hospital Center. 27th University of Montreal Annual Ophthalmology Research Day. Montreal, Canada
  • (2015). Glaucoma Surgery in Boston Type 1 Keratoprosthesis Patients at the University of Montreal Hospital Center. Annual Meeting and Exhibition of the Canadian Ophthalmological Society (COS). Victoria, Canada
  • (2014). Conditioning of Stem Cells with Celastrol to Optimize their Effect in Cellular Regenerative Therapy. COPSE Symposium, University of Montreal. Montreal, Canada
  • (2013). Conditioning of Stem Cells with Celastrol to Optimize their Effect in Cellular Regenerative Therapy. 5th Annual Meeting of the Cell, Tissue and Gene Therapy Quebec Network (ThéCell-FRQS). Montreal, Canada
  • (2013). Conditioning of Stem Cells with Celastrol to Optimize their Effect in Cellular Regenerative Therapy. 16th Annual Research Day of the CHUM Research Centre (CRCHUM). Montreal, Canada
  • (2013). Conditioning of Stem Cells with Celastrol to Optimize their Effect in Cellular Regenerative Therapy. 11th Annual Meeting and Exhibition of the Quebec Society of Vascular Sciences (SSVQ). Quebec, Canada